ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients.
Kar A, Koto K, Walker D, Trudeau T, Edgerton S, Thor A, Gutierrez-Hartmann A. ETS transcription factor ESE-1/Elf3 is an independent prognostic factor of survival in HR+HER2+ breast cancer patients. Breast Cancer Res Treat. 2020 Aug; 182(3):601-612.